跳至主要内容
临床试验/NCT02811718
NCT02811718已完成不适用

Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2016年7月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
45
试验地点
2
主要终点
Penn Acoustic Neuroma Quality-of Life Scale (PANQOL)

研究概览

简要总结

The aim of this study is to determine, whether the 3RP is feasible, accepted and efficacious and durable when delivered via Skype to patients with neurofibromatosis type 2 (NF2) who are deaf or have severe hearing loss using Communication Access Realtime Translation (CART) and/or American Sign Language (ASL).

This will be a substudy of the IRB-approved protocol #2013P002605. It is the same study except it is looking at a particular sub-population: patients with NF2 who are hard of hearing.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 or older
  • Can read and speak English at or above the 6th grade level
  • Patients with NF2 who are deaf or have severe hearing loss.

排除标准

  • Severe active or untreated major mental illness that would interfere with study participation, to be determined at the discretion of the study investigator (e.g. untreated psychosis or suicidality)
  • Recent (within past 3 months) change in antidepressant medication
  • Use of formal relaxation training (including past participation in a mind-body program), currently or in the past 6 months.
  • Unable or unwilling to sign the informed consent documents
  • Unable or unwilling to complete psychological assessments online via the REDCap system.
  • Unable or unwilling to participate in an intervention delivered via videoconferencing with Skype.
  • Unwilling to use either CART or ASL for communication during the Skype groups.

研究组 & 干预措施

Stress Management Group 1

Experimental

Subjects will attend group stress management sessions via Skype once weekly for 8 weeks and learn stress/NF symptoms managements techniques.

干预措施: Stress Management Group 1 (Behavioral)

Stress Management Group 2

Experimental

Subjects will attend group stress management sessions via Skype once weekly for 8 weeks and learn stress/NF symptoms managements techniques.

干预措施: Stress Management Group 2 (Behavioral)

结局指标

主要结局

Penn Acoustic Neuroma Quality-of Life Scale (PANQOL)

时间窗: Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32 and week 64)

The PANQOL measures quality of life specifically for patients with NF2.

Quality of Life (WHOQOL-BREF)

时间窗: Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32 and week 64)

The WHOQOL-BREF comprises of 26 items which measure the following broad domains: physical health, psychological health, social relationships, and environment. The WHOQOL-BREF is a shorter version of the original instrument that may be more convenient for use in large research studies or clinical trials.

次要结局

  • Cognitive and Affective Mindfulness Scale (CAMS)(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • The 14-Item Resiliency Scale (RS-14)(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • Perceived Stress Scale (PSS-10)(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • The Gratitude Questionnaire (GQ-6)(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • Medical Outcomes Study (MOS) Social Support Survey(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • Measure of Current Status (MOCS-A)(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • Patient Health Questionnaire (PHQ)(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • Life Orientation Test (LOT) Optimism Scale(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ana-Maria Vranceanu, PhD

Clinical Psychologist

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验